Search IPOs
FABTECH · NSE,BSE · Medical Equipment & Supplies
Fabtech Technologies IPO listed on 07 Oct 2025 on NSE,BSE at ₹192.00, a gain of 0.52% over the issue price of ₹191.00. The IPO was subscribed 2.03x overall.
Fabtech Technologies IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 29 Sep 2025 |
| IPO Close Date | 01 Oct 2025 |
| Basis of Allotment | 03 Oct 2025 |
| Initiation of Refunds | 06 Oct 2025 |
| Credit of Shares to Demat | 06 Oct 2025 |
| Listing Date | 07 Oct 2025 |
Listing day gain
+0.52%
Listed at ₹192 (issue ₹191)
Issue
₹191
Listing
₹192
Current
₹182.4
-4.5% vs issue
Day range
₹182.4 – ₹192.5
Issue Size
12,058,555 shares
(aggregating up to ₹230.30 Cr)
Issue Price
₹181 – ₹191
Face Value
₹10/share
Market Lot
75 shares
Retail Min Investment
₹14,325
Listing At
NSE,BSE
Sale Type
fresh issue
Fresh Issue
12,058,555 shares
(aggregating up to ₹230.3 Cr)
Offer for Sale
[.]
Employee Discount
₹9
Issue Type
book building
Open Date
29 Sep
Close Date
01 Oct
Allotment
03 Oct
Listing
07 Oct
Last updated: 11 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 07 Oct 2025 Latest | ₹191 | ₹0 | ₹191 | ₹0 |
0%
|
12:00 AM |
| 06 Oct 2025 | ₹191 | ₹0 | ₹191 | ₹0 |
0%
|
12:00 AM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 07 Oct 2025
| Category | Subscribed (x) |
|---|---|
| QIB | 2.02x |
| NII | 1.97x |
| bNII (bids above ₹10L) | 1.65x |
| sNII (bids below ₹10L) | 2.6x |
| Retail Investors | 2.08x |
| Employees | 2.01x |
| Total | 2.03x |
Showing the latest subscription snapshot.
View full subscription historyAasif Ahsan Khan, Hemant Mohan Anavkar, Aarif Ahsan Khan and Manisha Hemant Anavkar
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 75 | ₹14,325 |
| Retail (Max) | 13 | 975 | ₹186,225 |
| S-HNI (Min) | 14 | 1,050 | ₹200,550 |
| S-HNI (Max) | 69 | 5,175 | ₹988,425 |
| B-HNI (Min) | 70 | 5,250 | ₹1,002,750 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only employee | 2 | No |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 6,002,526 (49.77%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
6,002,526 (49.77%) |
| NII (HNI) Shares Offered | 1,800,759 (14.93%) |
|
•
bNII > ₹10L
|
1,200,506 (9.95%) |
|
•
sNII < ₹10L
|
600,253 (4.98%) |
| Retail Shares Offered | 4,201,770 (34.84%) |
| Employee | 54,945 (0.46%) |
| Total Shares Offered | 12,060,000 (100.00%) |
Fabtech Technologies Cleanrooms Limited was originally incorporated as Fabtech Turnkey Projects International Private Limited on June 3, 2015, in Mumbai. Following the demerger of the Modular Panels Division of Fabtech Technologies International Limited into the company in 2020, it was renamed Fabtech Technologies Cleanrooms Private Limited, and converted into a public limited company on July 5, 2024. It is headquartered in Mumbai and works in the cleanroom construction sector.
The company provides design-to-validation solutions for cleanroom construction, primarily serving the pharmaceutical, healthcare and biotech industries. It designs, manufactures and installs cleanroom components including modular wall panels, view panels, doors, risers, ceiling panels, covings, HVAC systems, epoxy flooring and electrical installations, complying with global regulatory standards such as FM Global. Its services span engineering, manufacturing, quality assurance, delivery, installation, commissioning and certification. Its manufacturing facility is located in Umbergaon, Valsad, Gujarat, spanning about 70,000 square feet, and its subsidiary Altair Partition Systems LLP manufactures economical-grade modular panels. Clients include Unichem Laboratories, Desano Pharmaceuticals and Apitoria Pharma. The company is promoted by Aasif Ahsan Khan, Aarif Ahsan Khan, Hemant Mohan Anavkar and Manisha Hemant Anavkar.
Revenue declined 22% and profit after tax declined 27% between FY23 and FY24, as per the DRHP. This was an SME IPO, listed on the NSE Emerge platform, comprising entirely a fresh issue of 32,64,000 equity shares of face value Rs 10 each, of which 1,64,800 shares were reserved for the market maker, at an issue price of Rs 85 per share, aggregating to about Rs 27.74 crore. Net proceeds were used for meeting long-term working capital requirements, the proposed acquisition of equity shares of Kelvin Air Conditioning and Ventilation Systems Private Limited, and general corporate purposes.
Standalone · ₹ in Crores
| Particulars | FY Mar 2023 | FY Mar 2024 | FY Mar 2025 |
|---|---|---|---|
| Total Revenue | 199.91 | 230.6 | 335.94 |
| Profit After Tax (PAT) | 21.58 | 27.22 | 46.33 |
| EBITDA | 32.38 | 39.75 | 47.28 |
| Total Assets | 213.86 | 269.24 | 426.56 |
| Net Worth | 88.96 | 131.88 | 173.11 |
| Reserves & Surplus | 86.18 | 128.94 | 140.72 |
| Total Borrowing | 34.29 | 9.88 | 54.62 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | Mar 2025 |
|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 30.46% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 24.46% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 26.83% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 13.83% |
| EBITDA Margin Earnings Before Interest, Tax, Depreciation and Amortisation Margin Profit from the main business as a share of sales, before loan interest and tax. Compare it with other companies in the same industry. | 14.07% |
| Debt / Equity Debt to Equity How much the company has borrowed against what shareholders own. Above 1x means the loans are bigger than shareholder funds. | 0.32x |
| P/BV Price to Book Value Tells you if the IPO price is above what the company actually owns. 1x to 3x is usually seen as reasonable. | 3.57x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹14.34 | ₹10.45 |
| P/E Price to Earnings Tells you if the IPO price is fair for what the company earns. Compare it with listed companies in the same sector. | 13.32x | 18.28x |
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | ₹619 Cr | ₹811 Cr |
The basis of allotment for Fabtech Technologies IPO was finalised on 03 Oct 2025. You can check your allotment status using your PAN number or application number on the Bigshare Services Private Limited portal or BSE.
The Fabtech Technologies IPO is expected to open in Sep 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Fabtech Technologies IPO is ₹181.00 - ₹191.00 per share.
As per market sources, Fabtech Technologies IPO GMP is currently ₹0.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Fabtech Technologies IPO stands at 2.03x overall.
The listing date for Fabtech Technologies IPO is 07 Oct 2025.
No comments yet. Be the first to comment!
